Phase 1 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older at the time of signing the consent form
- People who have a solid tumour that has been confirmed by laboratory testing of a tissue or cell sample, and that cannot be surgically removed, has come back, has spread locally, or has spread to other parts of the body
- People whose cancer shows measurable signs of disease based on specific imaging standards, as assessed by the trial site
Who may not be able to join:
- People who have been diagnosed with a condition that weakens the immune system
- People who have previously had a stem cell, bone marrow, or organ transplant
- People with a known history of HIV infection
- People with an active or ongoing hepatitis B or hepatitis C infection
- People who have an autoimmune disease (not caused by immunotherapy) that has needed medical treatment — such as steroids or immune-suppressing drugs — within the past 2 years
- People who have a history of lung inflammation (not caused by infection) that needed steroid treatment, or who currently have active lung inflammation or scarring of the lung tissue
- People whose cancer has spread in a way that the trial doctor believes could cause life-threatening complications in the near future, such as large uncontrolled fluid build-ups, cancer spreading through the lung's lymph vessels, or more than half of the liver being affected
- People with currently active cancer that has spread to the brain or the lining around the brain — though people with previously treated brain metastases may still be considered if scans show the cancer has been stable for at least 2 weeks, they are doing well clinically, and they have not needed steroid treatment for at least 14 days before starting the trial (confirm with trial site)
- People who have had a separate, second cancer diagnosed within the past 3 years — though certain exceptions may apply for some low-risk or localised skin cancers and other specific situations (confirm with trial site)
- People with a known mental health condition or substance use disorder that could make it difficult to follow the requirements of the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +1 (650) 442-3367
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety and Tolerability; Determine Recommended Dose for Expansion; Characterize Pharmacokinetics
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.